Trial intelligence / Profile preview

Tranexamic acid versus vaginal misoprostol with catheter tourniquet for blood loss reduction during open abdominal myomectomy

PACTR202506900439697Not yet recruiting

Sponsor
Dr Edward Sunday the reseacher
Start
Jul 2025
Modality
Small Molecules
Countries
1
01

Overview

Randomised, open-label trial in Fibromyoma (LM) comparing Tranexamic acid group with Misoprostol group (2 arms). Primary endpoint: Mean intra-operative blood loss. Planned start Jul 2025; status: not yet recruiting.

02

Drugs

tranexamic acidmisoprostol
03

Conditions

Fibromyoma (LM)

Beyond the preview

Go deeper on PACTR202506900439697.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on PACTR202506900439697.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call